Branched-Chain Amino Acids in Parkinson’s Disease: Molecular Mechanisms and Therapeutic Potential
International Journal of Molecular Sciences · 21.07.2025 · 26 (14) · 6992
DOI: 10.3390/ijms26146992 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.07.2025. Verfasst von Hui-Yu Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Metabolism and Obesity Sciences, College of Nutrition, Taipei Medical University, Taipei 11031, Taiwan. Hauptthemen laut MEDLINE: Parkinson Disease, Amino Acids, Branched-Chain. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taiwan, Ministry of Education, Taiwan under the 871 Higher Education Sprout Project, Ministry of Education, Taiwan under the Higher Education Sprout Project.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the selective loss of dopaminergic neurons in the substantia nigra, resulting in motor symptoms such as bradykinesia, tremor, rigidity, and postural instability, as well as a wide variety of non-motor manifestations. Branched-chain amino acids (BCAAs)—leucine, isoleucine, and valine—are essential nutrients involved in neurotransmitter synthesis, energy metabolism, and cellular signaling. Emerging evidence suggests that BCAA metabolism is intricately linked to the pathophysiology of PD. Dysregulation of BCAA levels has been associated with energy metabolism, mitochondrial dysfunction, oxidative stress, neuroinflammation, and altered neurotransmission. Furthermore, the branched-chain ketoacid dehydrogenase kinase (BCKDK), a key regulator of BCAA catabolism, has been implicated in PD through its role in modulating neuronal energetics and redox homeostasis. In this review, we synthesize current molecular, genetic, microbiome, and clinical evidence on BCAA dysregulation in PD to provide an integrative perspective on the BCAA–PD axis and highlight directions for future translational research. We explored the dualistic role of BCAAs as both potential neuroprotective agents and metabolic stressors, and critically examined the therapeutic prospects and limitations of BCAA supplementation and BCKDK targeting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Metabolism and Obesity Sciences, College of Nutrition, Taipei Medical University, Taipei 11031, Taiwan.
- Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
- Research Center for Digestive Medicine, Taipei Medical University Hospital, Taipei 11031, Taiwan.
- Nutrition Research Center, Taipei Medical University Hospital, Taipei 11031, Taiwan.
- Neuroscience Research Center, Taipei Medical University, Taipei 11031, Taiwan.
- Department of Neurology, Taipei Medical University Hospital, Taipei 11031, Taiwan.
ORCID-Profile: Hui-Yu Huang, Shu-Ping Tsao, Tu-Hsueh Yeh
Förderung
- National Science and Technology Council, Taiwan
- Ministry of Education, Taiwan under the 871 Higher Education Sprout Project
- Ministry of Education, Taiwan under the Higher Education Sprout Project
Zitieren
APA
Huang, H. Y., Tsao, S. P., & Yeh, T. H. (2025). Branched-Chain Amino Acids in Parkinson’s Disease: Molecular Mechanisms and Therapeutic Potential. International Journal of Molecular Sciences, 26(14), 6992. https://doi.org/10.3390/ijms26146992
Vancouver
Huang HY, Tsao SP, Yeh TH. Branched-Chain Amino Acids in Parkinson’s Disease: Molecular Mechanisms and Therapeutic Potential. International Journal of Molecular Sciences. 2025;26(14):6992. doi:10.3390/ijms26146992
BibTeX
@article{Huang2025,
author = {Huang, Hui-Yu and Tsao, Shu-Ping and Yeh, Tu-Hsueh},
title = {Branched-Chain Amino Acids in Parkinson’s Disease: Molecular Mechanisms and Therapeutic Potential},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {14},
pages = {6992},
doi = {10.3390/ijms26146992}
}
EUVIMED